The pharmaceutical firm was one of the contributors to the first fund closed by healthcare tchnology accelerator Start Codon, at $19.7m.
UK-based healthcare and life sciences accelerator Start Codon closed its first venture capital fund at £15m ($19.7m) with backing from pharmaceutical firm Novartis and Cambridge Innovation Capital (CIC) yesterday.
Founded in April 2019, Start Codon recently enrolled its second cohort on the way to its target of sustaining 50 startups in its target sectors, with each set to be equipped with at least £250,000 in seed funding in addition to mentoring and access to lab resources.
The accelerator showcased its…
